These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8260090)

  • 1. Interactions between peptides and major histocompatibility complex molecules during antigen processing and presentation.
    Forquet F; Danilczyk U; Lang Y; Delovitch TL
    Chem Immunol; 1993; 57():63-87. PubMed ID: 8260090
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigen processing and presentation.
    Wilson IA
    Clin Transplant; 1995 Jun; 9(3 Pt 2):260-1. PubMed ID: 7670173
    [No Abstract]   [Full Text] [Related]  

  • 3. Faulty major histocompatibility complex class I function linked to autoimmune diabetes.
    Faustman D
    Transplant Proc; 1992 Dec; 24(6):2874-6. PubMed ID: 1465979
    [No Abstract]   [Full Text] [Related]  

  • 4. The major histocompatibility complex in man.
    Buc M
    Folia Biol (Praha); 1993; 39(5):223-42. PubMed ID: 8206168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen processing: a critical factor in rational vaccine design.
    Yewdell JW; Bennink JR
    Semin Hematol; 1993 Oct; 30(4 Suppl 4):26-32; discussion 33-4. PubMed ID: 8303307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloantigen processing and presentation.
    Tambur AR; Gebel HM
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1031-7. PubMed ID: 8719446
    [No Abstract]   [Full Text] [Related]  

  • 7. Peptides made to order.
    Rammensee HG
    Immunity; 2006 Nov; 25(5):693-5. PubMed ID: 17098199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indirect presentation of MHC antigens in transplantation.
    Shoskes DA; Wood KJ
    Immunol Today; 1994 Jan; 15(1):32-8. PubMed ID: 8136009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunology. Inside the gearbox of the dendritic cell.
    Watts C
    Nature; 1997 Aug; 388(6644):724-5. PubMed ID: 9285579
    [No Abstract]   [Full Text] [Related]  

  • 10. Peptide-MHC complexes assembled following multiple pathways: an opportunity for the design of vaccines and therapeutic molecules.
    Corradin G; Demotz S
    Hum Immunol; 1997 May; 54(2):137-47. PubMed ID: 9297532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C; Rogers WO; Gowda K; Doolan DL
    Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.
    Watts C
    Nat Immunol; 2004 Jul; 5(7):685-92. PubMed ID: 15224094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ER aminopeptidases generate a unique pool of peptides for MHC class I molecules.
    Serwold T; Gaw S; Shastri N
    Nat Immunol; 2001 Jul; 2(7):644-51. PubMed ID: 11429550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules.
    Hammer GE; Gonzalez F; Champsaur M; Cado D; Shastri N
    Nat Immunol; 2006 Jan; 7(1):103-12. PubMed ID: 16299505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MHC class II restricted antigen presentation].
    Kuida K
    Tanpakushitsu Kakusan Koso; 1997 Oct; 42(14 Suppl):2376-9. PubMed ID: 9366221
    [No Abstract]   [Full Text] [Related]  

  • 16. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.
    Rodriguez A; Regnault A; Kleijmeer M; Ricciardi-Castagnoli P; Amigorena S
    Nat Cell Biol; 1999 Oct; 1(6):362-8. PubMed ID: 10559964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular engineering of the major histocompatibility complex for immunomodulation.
    Ghobrial RR; Stepkowski SM; Kahan BD
    Clin Transplant; 1995 Jun; 9(3 Pt 2):237-45. PubMed ID: 7670169
    [No Abstract]   [Full Text] [Related]  

  • 19. Presentation of antigens derived from microorganisms residing in host-cell vacuoles.
    Ojcius DM; Gachelin G; Dautry-Varsat A
    Trends Microbiol; 1996 Feb; 4(2):53-9. PubMed ID: 8820567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide binding and antigen presentation by class II histocompatibility glycoproteins.
    Jensen PE
    Biopolymers; 1997; 43(4):303-22. PubMed ID: 9316394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.